COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02978625
Brief Title: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

First Submitted : November 30, 2016
First Submitted that Met QC Criteria : November 30, 2016
First Posted : December 1, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 22, 2020
Last Update Posted : October 23, 2020